2 July 2024 - PHARMAC’s quarterly Pūahoaho Report contains the latest information about applications for medicines, vaccines, and related products that we’ve assessed for funding in New Zealand.

During the June 2024 prioritisation quarter, we ranked 14 proposals on the options for investment list, and re-prioritised seven others. Re-prioritisation can occur due to more information becoming available, or a change in an application’s Factors for Consideration relative to other funding options.

Read PHARMAC press release